Clinical trial

Alogliptin Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Monotherapy/Combination Therapy With α-GI"

NCT01945216

Study summary

ClinicalTrials.gov

Alogliptin Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Monotherapy/Combination Therapy With α-GI"

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record Alogliptin Normalized identity: alogliptin View linked drug · Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2010-07-08

PhaseN/A

Conditions

Type 2 Diabetes Mellitus Who Have Been Examined at a Medical Institutionunresolved

Interventions

AlogliptinDRUG · verified · RxNorm: alogliptin

Sponsors & collaborators

Takedalead sponsor

Mapped research locations

OsakaJapan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01945216 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.